치료 계획 시스템 및 첨단 영상 처리 시장 규모, 점유율, 동향 분석 보고서 : 구성요소별, 기술별, 용도별, 지역별, 부문별 예측(2024-2030년)

Treatment Planning Systems And Advanced Image Processing Market Growth & Trends:

The global treatment planning systems and advanced image processing market size is expected to reach USD 3.47 billion by 2030, registering a CAGR of 8.76% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing number of cancer cases and increasing digitalization of healthcare facilities are some of the major factors anticipated to propel the adoption of treatment planning systems and advanced image processing solutions over the years. According to WHO, there are around 10 million deaths due to cancer in 2020, which is accounted for about one in every six deaths. In addition, the growing advancement of medical imaging and radiotherapy with integrated AI systems to diagnose tumors or cancer is also anticipated to fuel market growth in the near future. Furthermore, increasing investments by the manufacturers to develop advanced image processing equipment further support market growth.

The treatment planning software segment dominated the market in 2022. This share of the segment is attributable to the increasing adoption of treatment planning software in radiation therapy to develop a plan for how the system will deliver the radiation. In addition, these software programs also help medical professionals to generate high-quality treatment plans such as the dose distribution in the patient's tissue and minimization of collateral damage from the therapy. Furthermore, the increase in innovation and growing adoption of Machine Learning (ML) and Artificial Intelligence (AI) based treatment planning software to improve diagnosis and treatment outcomes further supports the growth of the segment.

The in-room imaging segment is anticipated to account for highest market revenue share of 55.2% in 2022. The increase in the number of complex radiotherapy procedures requires in-room image guidance to improve accuracy and precision. Furthermore, the rise in preference and adoption of in-room imaging technology by the healthcare and radiology facilities for decision-making and intervention is also expected to accelerate the segment growth.

In addition, the validation of the image registration segment accounts for a high revenue share of 27.3% in 2022 by application owing to the increasing use of treatment planning systems for accuracy validation in medical image registration techniques, which is very essential in several clinical applications.

North America dominated the market in terms of the revenue share of 38.3% in 2022 followed by Europe. The increasing number of cancer patients and the presence of advanced healthcare infrastructure are some of the major factors for the high revenue share of this region. In addition, increasing healthcare expenditure and high adoption of advanced medical imaging technology is further supporting to the growth of this segment. Moreover, the presence of skilled medical professionals and rapid shift towards the digitalization of healthcare infrastructure is also anticipated to fuel market growth in North America.

Moreover, the COVID-19 pandemic has changed the way of medical services. The increasing adoption of healthcare digitalization platforms with AI and machine learning integration has positively impacted the market growth during the COVID-19 pandemic. Moreover, the increase in online patient monitoring and the growing development of advanced image processing and treatment planning software further propelled market growth. Increasing government initiatives for remote diagnosis of patients and the growing number of cancer patients also drove the adoption of treatment planning software. However, the interruption of the supply chain, shortage, and shifting of medical staff to manage coronavirus disease has certainly reduced the number of medical imaging procedures which in turn moderately impacted the adoption of advanced medical imaging technology.

Treatment Planning Systems And Advanced Image Processing Market Report Highlights:

• The market is anticipated to witness significant growth of 8.76% over the forecast period owing to increasing prevalence of cancer and rising AI based product development activities for better treatment planning and advanced image processing
• The treatment planning software segment dominated the market by capturing a share of in 2023, owing to increased demand for accurate and precise treatment options
• The in-room imaging segment accounted for the largest revenue share of 55.1% in 2023, owing to increase in number of complex radiotherapy procedures, which requires in-room image guidance to improve the accuracy and precision
• The validation of the image registration segment accounted for the highest revenue share of 27.3% in 2023 owing to increasing use of treatment planning systems for accuracy validation in medical image registration techniques
• North America treatment planning systems and advanced image processing market held the largest share of 38.9% in 2023 owing to the increasing number of cancer patients and presence of advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Component
  • 1.2.2. Technique
  • 1.2.3. Application
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component outlook
  • 2.2.2. Technique outlook
  • 2.2.3. Application outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Treatment Planning Systems and Advanced Image Processing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cancer
    • 3.2.1.2. Increasing investments and strategic initiatives in radiology and oncology
    • 3.2.1.3. Increasing number of radiotherapy centers and hospitals adopting technologically advanced radiotherapy machines and software
    • 3.2.1.4. Rising adoption of AI/ML in oncology software
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Shortage of healthcare personnel in information technology and radiology sector
    • 3.2.2.2. Capital intensive market
  • 3.2.3. Market challenge analysis
    • 3.2.3.1. Cybersecurity and privacy concerns
  • 3.2.4. Market opportunity analysis
    • 3.2.4.1. Real-time monitoring and tracking of cancer progression
• 3.3. Treatment Planning Systems And Advanced Image Processing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Treatment Planning Systems and Advanced Image Processing Market: Component Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Treatment Planning Systems And Advanced Image Processing Component Market Movement Analysis
• 4.3. Global Treatment Planning Systems And Advanced Image Processing Market Size & Trend Analysis, by Component, 2018 to 2030 (USD Million)
• 4.4. Advanced Image Processing Software
  • 4.4.1. Advanced image processing software market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Treatment Planning Software
  • 4.5.1. Treatment planning software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Auto-contouring software
    • 4.5.2.1. Auto-contouring software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Multi-modality software
    • 4.5.3.1. Multi-modality software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. PET/CT deformable software
    • 4.5.4.1. PET/CT deformable software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.5. DICOM-RT software
    • 4.5.5.1. DICOM-RT software market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Treatment Planning Systems and Advanced Image Processing Market: Technique Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Treatment Planning Systems and Advanced Image Processing Technique Market Movement Analysis
• 5.3. Global Treatment Planning Systems and Advanced Image Processing Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
• 5.4. 3D Image Reconstruction
  • 5.4.1. 3D image reconstruction market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. In-Room Imaging
  • 5.5.1. In-room imaging market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Image Registration using Graphics Processor Unit
  • 5.6.1. Image registration using graphics processor unit market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Treatment Planning Systems and Advanced Image Processing Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Treatment Planning Systems and Advanced Image Processing Application Market Movement Analysis
• 6.3. Global Treatment Planning Systems and Advanced Image Processing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Adaptive Radiotherapy
  • 6.4.1. Adaptive radiotherapy market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Online Monitoring
  • 6.5.1. Online monitoring market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Tracking
  • 6.6.1. Tracking market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Dose Accumulation
  • 6.7.1. Dose accumulation market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Validation of Image Registration
  • 6.8.1. Validation of image registration market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Treatment Planning Systems And Advanced Image Processing Market: Regional Estimates & Trend Analysis By Product , Application, Modality, End Use

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework/ reimbursement structure
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework/ reimbursement structure
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework/ reimbursement structure
    • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework/ reimbursement structure
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework/ reimbursement structure
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework/ reimbursement structure
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework/ reimbursement structure
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework/ reimbursement structure
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework/ reimbursement structure
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework/ reimbursement structure
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework/ reimbursement structure
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework/ reimbursement structure
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework/ reimbursement structure
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework/ reimbursement structure
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework/ reimbursement structure
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework/ reimbursement structure
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework/ reimbursement structure
    • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework/ reimbursement structure
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework/ reimbursement structure
    • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework/ reimbursement structure
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework/ reimbursement structure
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework/ reimbursement structure
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework/ reimbursement structure
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market share analysis, 2023
• 8.4. Company Position Analysis
• 8.5. Company Categorization (Emerging Players, Innovators and Leaders
• 8.6. Company Profiles
  • 8.6.1. Accuray Incorporated
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. Elekta
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. Philips Healthcare
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. RaySearch Laboratories
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. Varian Medical Systems
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. Brainlab
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. Prowess Inc.
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. DOSIsoft SA
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. ViewRay Inc.
    • 8.6.9.1. Company overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives
  • 8.6.10. MIM Software Inc.
    • 8.6.10.1. Company overview
    • 8.6.10.2. Financial performance
    • 8.6.10.3. Product benchmarking
    • 8.6.10.4. Strategic initiatives